Anti-Human CD3E Recombinant Antibody(Visilizumab)_天津卡梅德科技发展有限公司

>>

>>

>>

>

Anti-Human CD3E Recombinant Antibody(Visilizumab)

Anti-Human CD3E Recombinant Antibody(Visilizumab)

产品编号

YR1046

别名

科研级 Visilizumab ( 维西珠单抗 ), Anti-CD3E Recombinant Antibody, Research Grade Visilizumab

规格

1mg
5mg

DATASHEET MSDS

立即询价加入询价列表大包装定制

产品介绍

Alias	科研级 Visilizumab ( 维西珠单抗 ), Anti-CD3E Recombinant Antibody, Research Grade Visilizumab
Catalog Number	YR1046
Molecular Name	Visilizumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG2
Formulation	PBS, pH7.5
Background	Visilizumab (tentative trade name Nuvion, PDL BioPharma Inc.) is a humanized monoclonal antibody. It is being investigated for use as an immunosuppressive drug in patients with ulcerative colitis and Crohn's disease. Visilizumab binds to the CD3 receptor on certain activated T cells without affecting resting T cells. It is currently under clinical studies for the treatment of ulcerative colitis and Crohn's disease.
CAS Number	219716-33-3
Application	ELISA, IHC, IF, IP, FCM, FuncS
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	CD3E[Homo sapiens]

推荐产品

400-621-6806
614353794
周一至周五 9:00-18:00
0